Nucl Med Mol Imaging.
2019 Aug;53(4):296-299. 10.1007/s13139-019-00597-8.
¹â¸F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma
- Affiliations
-
- 1Department of Biomedical and Dental Sciences and of Morpho-functional Imaging, Nuclear Medicine Unit, University of Messina, Messina, Italy. riclaudi@hotmail.it
- 2Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, USA.
- 3Department of Radiology, Stanford University, Stanford, USA.
- KMID: 2455525
- DOI: http://doi.org/10.1007/s13139-019-00597-8
Abstract
- We described the clinical impact of ¹â¸F-FDG PET/MR in refining the evaluation of a 39-year-old female with newly diagnosed metastatic urethral adenocarcinoma.We detailed the diagnostic imaging workup focusing our attention on the CT, MR, and ¹â¸F-FDG PET/MR different findings. In this case, ¹â¸F-FDG PET/MR imaging evaluation resulted not only effective but also altered staging and spared additional invasive procedures in the assessment of a metastatic urethral adenocarcinoma. Combining a highly sensitive PET with the increase tissue resolution of MR (PET/MR) may improve abdominal and pelvic lesion detection outperforming PET/CT for this indication.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Potential Clinical Applications of ¹â¸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer
- Unusual Horner's Syndrome in Recurrent Breast Cancer: Evaluation Using ¹â¸F-FDG PET/CT
- Comparison of Neck CT and ¹â¸F-FDG PET-CT for Making the Preoperative Diagnosis of Lymph Node Metastasis in Papillary Thyroid Cancer
- Role of ¹â¸F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer: 2 Case Reports
- Primary Renal Leiomyosarcoma Presenting with Subcutaneous and Osseous Metastases: Staging and Follow-Up with 18F-FDG PET/CT
